Search results
What You Should Know About Medications for Osteoporosis
Verywell Health via Yahoo News· 1 year agoMedically reviewed by Stella Bard, MD There are many medication options to treat osteoporosis, a...
Amgen (AMGN) Q4 Earnings Top, Horizon Drugs Drive Sales
Zacks via Yahoo Finance· 4 months agoAmgen AMGN reported fourth-quarter 2023 adjusted earnings of $4.71 per share, which beat the Zacks...
Amgen Sweetens Full-Year Outlook After Narrowly Beating Third-Quarter Forecasts
Investor's Business Daily· 2 years agoAmgen stock popped Friday after the drugmaker sweetened its 2022 outlook following a third-quarter...
Amgen (AMGN) to Report Q3 Earnings: Will It Beat Estimates?
Zacks via Yahoo Finance· 7 months agoVolume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is...
Amgen (AMGN) Q2 Earnings Beat Estimates, 2023 View Raised
Zacks via Yahoo Finance· 10 months agoAmgen AMGN reported second-quarter 2023 earnings of $5.00 per share, which beat the Zacks Consensus...
Amgen (AMGN) to Report Q2 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 10 months agoVolume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is...
What's in the Cards for Amgen (AMGN) This Earnings Season?
Zacks via Yahoo Finance· 1 month agoVolume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others, is...
Why Is Amgen (AMGN) Down 4.2% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 year agoIt has been about a month since the last earnings report for Amgen (AMGN). Shares have lost about...
Amgen (AMGN) Stock Outperforms Industry YTD: Here's Why
Zacks via Yahoo Finance· 9 months agoAmgen (AMGN) expects strong sales growth of products like Tezspire, Evenity and Repatha to be offset...
Amgen Is 'Confident' It Can Wrap The Horizon Takeover By December
Investor's Business Daily· 10 months agoAmgen stock jumped Friday after the biotech behemoth broadly topped Wall Street's second-quarter...